Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
급성호흡곤란증후군의 간엽줄기세포치료제: 기초부터 임상까지
Review
[키워드] 2019 novel coronavirus
2019 novel coronavirus disease
acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
alveolar fluid clearance
anti-apoptotic
Anti-inflammatory
approaches
ARDS
Bacterial
breath
caused
Cell
cell damage
Cell therapy
China
clinical study
clinics
coronavirus
coronavirus disease
COVID-19
COVID-19 patient
develop
disease
disrupt
distal
Effects
Efficacy
ENhance
epithelial
epithelial cell
event
Extracellular vesicles
Factor
high mortality
intrinsic
limit
lung
mechanism
mesenchymal stem cell
Mesenchymal stem cells
morbidity
MSC
MSC therapy
multiple organ failure
Novel coronavirus
novel coronavirus disease
occurred
optimization
Organ failure
organ injury
paracrine
pathophysiological
patients with ARDS
Pneumonia
promote
pulmonary endothelial
respiratory
respiratory distress
SARS-CoV-2
SARS-CoV-2-infected patient
SARS-CoV-2-infected patients
severe acute respiratory syndrome Coronavirus
severe pneumonia
stem cell
supportive care
survival
syndrome
therapeutic
therapy
variety
[DOI] 10.1007/s13238-020-00738-2 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s13238-020-00738-2 PMC 바로가기 [Article Type] Review